Alta Schutte honoured with NHMRC Research Excellence Award
'ecoSwitch' recognised at 35th Banksia Awards for sustainability
Diabetes drug improves cardiovascular outcomes across a range of heart and kidney conditions
Meet Dr Kate Womersley: embedding equity to deliver better science
New research shows urgency to act on Nigeria’s trans fat elimination policy
Addressing sex and gender bias in health: now is the time
Transforming the delivery of NCD and mental health services in primary health care: Launch of the fourth cycle of the NCD Lab
New funding to boost prevention and improve treatment of chronic conditions
Dr Chris Butler
Chris is the Programme Director for Multiple Long-Term Conditions at The George Institute for Global Health, UK and Clinical Reader in Global Brain Health at Imperial College London. He works clinically as a Cognitive Neurologist at Imperial College Healthcare NHS Trust in London.
He has a particular interest in the impact of multiple long-term conditions upon cognitive function in low and middle income countries and leads a programme of research on dementia and its co-morbidities in Latin America. His work is driven by the belief that high-quality, multi-disciplinary science can and should drive changes in public policy for the benefit of those most in need.
Chris trained in medicine at the universities of Cambridge and Edinburgh and completed specialist training in cognitive neurology in San Francisco and Oxford. His research has explored the ways in which memory and thinking are affected by brain diseases such as dementia and epilepsy. At The George Institute and Imperial College London, Chris’ work focuses on evaluating and improving brain health amongst disadvantaged communities and understanding how this relates to burden of chronic disease.
Peeyush Gupta AM
Peeyush Gupta AM is a Non-Executive Director of SBS, Northern Territory Aboriginal Investment Corporation, Quintessence Labs, Dexus, NSW Cancer Council and Liberty Financial Group.
Peeyush was the co-founder and inaugural CEO of IPAC Securities. He was awarded a Member of the Order of Australia (AM) for significant service to business and the community through governance and philanthropic roles.
Peeyush joined the Board in February 2024 and is a Member of the Audit Committee and Investment Committee.
Dr Sue Haupt
Dr Sue Haupt is a Research Associate at The George Institute for Global Health, the Women’s Health Program, and is also an Honorary Senior Research in the Sir Peter MacCallum Department of Oncology at UoM. She focuses on sex disparities in medical research and health and has a track record of commitment to humanitarian research projects for health equity around the globe. She is internationally recognised for original, ground-breaking, research discoveries of sex differences in cancer (93 articles). She is an advocate for sex and gender policies in medical research and care on ABC Health Report (2019, 2021), which aligns directly with her contribution to the Launch of the Australian Centre for Sex and Gender Equity in Health and Medicine in March 2024 at UNSW. She is an invited speaker on sex disparities at international medical conferences and across a breadth of diverse, national public forums. A medical science writer of original research (e.g. NatComms), reviews, commentaries and perspectives (e.g. NatMed, including features on sex disparities in health (e.g. NatRevCancer). She is committed to educating the next generation of research scientists and has extensive experience as a: graduate student supervisor (8 PhD, 1 ongoing, 2 MA students and 6 Honours students, all H1 graduates); mentor; chair and member of university student committees.